Arsenic Toxicity in Emergency Medicine Medication
- Author: Steven Marcus, MD; Chief Editor: Asim Tarabar, MD more...
Medication Summary
Treatment of acute arsenic toxicity is supportive. Chelation therapy is imperative in all symptomatic patients; however, the use of chelators in patients exposed to arsine gas is controversial. The efficacy of chelation therapy in providing either laboratory or clinical improvement in intoxicated patients is lacking.
The physician is reminded to look carefully at laboratory tests. Generally, organic arsenical compounds found in the urine are not an indication of arsenic toxicity and do not warrant therapeutical intervention.
Hemodialysis, in the absence of renal failure, has not been shown to alter medical outcome. The use of extracorporeal membrane oxygenation in an infant who developed cardiovascular collapse did not result in survival.
Chelating agents
Class Summary
Bind heavy metals and to hasten excretion. By binding in plasma, they render heavy metals nontoxic.
Dimercaprol (BAL in Oil)
First-line agent available in the US for treating arsenic poisoning. Often in short supply, is one of the antidotes considered essential to be stocked by every ED.
Administered IM q4h, mixed in a peanut oil base. Excreted in urine and bile. May be administered to patients with renal failure.
Succimer (DMSA)
Licensed by the FDA for use only in childhood lead poisoning. Has been used worldwide as a heavy metal chelator and has been efficacious in treating arsenic intoxications. In the US, is only available in a bead-filled oral capsule of 100 mg.
Dimerval (DMPS)
Internationally accepted DOC for treating most heavy metal poisonings. Not licensed for use in the US and must be obtained from Helytex in Houston. Available as either a parenteral or oral form.
Gensheimer KF, Rea V, Mills DA, Montagna CP, Simone K. Arsenic poisoning caused by intentional contamination of coffee at a church gathering--an epidemiological approach to a forensic investigation. J Forensic Sci. Jul 2010;55(4):1116-9. [Medline]. [Full Text].
Mandal BK, Suzuki KT. Arsenic round the world: a review. Talanta. Aug 16 2002;58(1):201-35. [Medline].
Sigmon C, Patch S. A pilot survey of in-service home arsenic tracked in from chromated copper arsenate-treated decks. J Environ Health. Jan-Feb 2010;72(6):18-22. [Medline].
Matos RC, Vieira C, Morais S, Pereira ML, Pedrosa J. Toxicity of chromated copper arsenate: a study in mice. Environ Res. Jul 2010;110(5):424-7. [Medline].
Kamchanawong S, Veerakajohnsak C. Arsenic, chromium, and copper leaching from CCA-treated wood and their potential impacts on landfill leachate in a tropical country. Environ Technol. Apr 1 2010;31(4):381-94. [Medline].
Emadi A, Gore SD. Arsenic trioxide - An old drug rediscovered. Blood Rev. Jul-Sep 2010;24(4-5):191-9. [Medline]. [Full Text].
Gong G, O'bryant SE. The Arsenic Exposure Hypothesis for Alzheimer Disease. Alzheimer Dis Assoc Disord. May 13 2010;[Medline].
Ettinger AS, Zota AR, Amarasiriwardena CJ, Hopkins MR, Schwartz J, Hu H, et al. Maternal arsenic exposure and impaired glucose tolerance during pregnancy. Environ Health Perspect. Jul 2009;117(7):1059-64. [Medline]. [Full Text].
Vahter M. Effects of Arsenic on Maternal and fetal Health. Annu Rev Nutr. June 2009;29:381-399. [Medline]. [Full Text].
Luna AL, Acosta-Saavedra LC, Lopez-Carrillo L, Conde P, Vera E, De Vizcaya-Ruiz A, et al. Arsenic alters monocyte superoxide anion and nitric oxide production in environmentally exposed children. Toxicol Appl Pharmacol. Jun 1 2010;245(2):244-51. [Medline].
Raghu KG, Yadav GK, Singh R, Prathapan A, Sharma S, Bhadauria S. Evaluation of adverse cardiac effects induced by arsenic trioxide, a potent anti-APL drug. J Environ Pathol Toxicol Oncol. 2009;28(3):241-52. [Medline].
Balakumar P, Kaur J. Arsenic exposure and cardiovascular disorders: an overview. Cardiovasc Toxicol. Dec 2009;9(4):169-76. [Medline].
Bronstein AC, Spyker DA, Cantilena LR Jr, Green JL, Rumack BH, Dart RC. 2010 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 28th Annual Report. Clin Toxicol (Phila). Dec 2011;49(10):910-41. [Medline].
Ng JC, Moore MR. Arsenic in drinking water: a natural killer in Bangladesh and beyond. An urgent alternative watershed management strategy is needed. Med J Aust. Dec 5-19 2005;183(11-12):562-3. [Medline]. [Full Text].
Zablotska LB, Chen Y, Graziano JH, Parvez F, van Geen A, Howe GR, et al. Protective effects of B vitamins and antioxidants on the risk of arsenic-related skin lesions in Bangladesh. Environ Health Perspect. Aug 2008;116(8):1056-62. [Medline].
Yoshimura Y, Endo Y, Shimoda Y, Yamanaka K, Endo G. Acute Arsine Poiosning Confirmed by Speciation Analysis of Arsenic Compounds in the Plasma and urine by HPLC-ICP-MS. J Occupational Health. Nov 2011;53:45-49. [Medline]. [Full Text].
Amster E, Tiwary A, Schenker MB. Case report: potential arsenic toxicosis secondary to herbal kelp supplement. Environ Health Perspect. Apr 2007;115(4):606-8. [Medline].
Borak J, Hosgood HD. Seafood arsenic: implications for human risk assessment. Regul Toxicol Pharmacol. Mar 2007;47(2):204-12. [Medline].
Duenas-Laita A, Perez-Miranda M, Gonzalez-Lopez MA, et al. Acute arsenic poisoning. Lancet. Jun 4-10 2005;365(9475):1982. [Medline].
Fesmire FM, Schauben JL, Roberge RJ. Survival following massive arsenic ingestion. Am J Emerg Med. Nov 1988;6(6):602-6. [Medline].
Gerhardt RE, Crecelius EA, Hudson JB. Moonshine-related arsenic poisoning. Arch Intern Med. Feb 1980;140(2):211-3. [Medline].
Graeme KA, Pollack CV Jr. Heavy metal toxicity, Part I: arsenic and mercury. J Emerg Med. Jan-Feb 1998;16(1):45-56. [Medline].
Hall JC, Harruff R. Fatal cardiac arrhythmia in a patient with interstitial myocarditis related to chronic arsenic poisoning. South Med J. Dec 1989;82(12):1557-60. [Medline].
Lai MW, Boyer EW, Kleinman ME, et al. Acute arsenic poisoning in two siblings. Pediatrics. Jul 2005;116(1):249-57. [Medline].
Lech T, Trela F. Massive acute arsenic poisonings. Forensic Sci Int. Jul 16 2005;151(2-3):273-7. [Medline].
Muckter H, Liebl B, Reichl FX, et al. Are we ready to replace dimercaprol (BAL) as an arsenic antidote?. Hum Exp Toxicol. Aug 1997;16(8):460-5. [Medline].
Navarro B, Sayas MJ, Atienza A, Leon P. An unhappily married man with thick soles. Lancet. Jun 8 1996;347(9015):1596. [Medline].
Severo R. Albany consumer unit calls sealant a health peril. NY Times Mag. Dec 30 1976;42.
Stenehjem AE, Vahter M, Nermell B, Aasen J, Lierhagen S, Morland J. Slow recovery from severe inorganic arsenic poisoning despite treatment with DMSA (2.3-dimercaptosuccinic acid). Clin Toxicol (Phila). May 2007;45(4):424-8. [Medline].

